Biopharma company sells feline weight-loss med for $43MMarch 31, 2020A mirtazapine transdermal ointment, used for the management of weight loss in cats, has just changed pharmaceutical hands in a multimillion dollar deal.
SPONSORED CONTENTLife-saving results for parvovirus casesResearch has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients. + Read More
Veterinary Hospitals Association partners with Kindred BioscienceJune 28, 2019Veterinary Hospitals Association (VHA) and Kindred Biosciences have struck up a partnership that will bring the biopharmaceutical company’s products into more than 420 VHA-represented clinics.
Kindred Biosciences' Mirataz commercially available in U.S.May 9, 2018Update: this product is now commercially available in the U.S. Kindred Biosciences Inc. has received approval from the U.S. Food & Drug Administration for Mirataz (mirtazapine transdermal ointment) for the management of weight loss in cats. Mirtazapine, which blocks specific serotonin and histamine receptors that play a role in appetite and nausea, demonstrated a 3.9 percent increase in body weight in cats with unintended weight loss in as little as 14 days, according to San …
